Barclays’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-48,607
| Closed | -$8.74M | – | 4348 |
|
2017
Q3 | $8.74M | Buy |
48,607
+44,533
| +1,093% | +$8.01M | 0.01% | 620 |
|
2017
Q2 | $423K | Buy |
4,074
+969
| +31% | +$101K | ﹤0.01% | 2006 |
|
2017
Q1 | $244K | Sell |
3,105
-16,768
| -84% | -$1.32M | ﹤0.01% | 2377 |
|
2016
Q4 | $891K | Sell |
19,873
-13,758
| -41% | -$617K | ﹤0.01% | 1549 |
|
2016
Q3 | $1.88M | Buy |
+33,631
| New | +$1.88M | ﹤0.01% | 1112 |
|
2016
Q2 | – | Sell |
-3,563
| Closed | -$160K | – | 4051 |
|
2016
Q1 | $160K | Buy |
3,563
+790
| +28% | +$35.5K | ﹤0.01% | 2153 |
|
2015
Q4 | $169K | Sell |
2,773
-465
| -14% | -$28.3K | ﹤0.01% | 2114 |
|
2015
Q3 | $178K | Buy |
3,238
+2,606
| +412% | +$143K | ﹤0.01% | 2163 |
|
2015
Q2 | $38K | Sell |
632
-35,189
| -98% | -$2.12M | ﹤0.01% | 2724 |
|
2015
Q1 | $2.04M | Buy |
35,821
+34,956
| +4,041% | +$1.99M | ﹤0.01% | 1254 |
|
2014
Q4 | $50K | Buy |
+865
| New | +$50K | ﹤0.01% | 3030 |
|